Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Sales

BioScience Health Innovations (BHIC) Debt Ratio (2019 - 2022)

Historic Debt Ratio for BioScience Health Innovations (BHIC) over the last 4 years, with Q2 2022 value amounting to 0.12.

  • BioScience Health Innovations' Debt Ratio fell 9973.19% to 0.12 in Q2 2022 from the same period last year, while for May 2022 it was 0.12, marking a year-over-year decrease of 9973.19%. This contributed to the annual value of 2.76 for FY2021, which is 62889.45% up from last year.
  • Per BioScience Health Innovations' latest filing, its Debt Ratio stood at 0.12 for Q2 2022, which was down 9973.19% from 0.04 recorded in Q1 2022.
  • In the past 5 years, BioScience Health Innovations' Debt Ratio registered a high of 44.12 during Q2 2021, and its lowest value of 0.04 during Q1 2022.
  • Over the past 4 years, BioScience Health Innovations' median Debt Ratio value was 0.7 (recorded in 2020), while the average stood at 5.1.
  • Per our database at Business Quant, BioScience Health Innovations' Debt Ratio surged by 1566737.04% in 2021 and then plummeted by 9973.19% in 2022.
  • BioScience Health Innovations' Debt Ratio (Quarter) stood at 0.76 in 2019, then dropped by 7.82% to 0.7 in 2020, then plummeted by 74.23% to 0.18 in 2021, then tumbled by 34.74% to 0.12 in 2022.
  • Its Debt Ratio stands at 0.12 for Q2 2022, versus 0.04 for Q1 2022 and 0.18 for Q4 2021.